Female Power Broker
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
<<< Don’t you thing company explaining the rationale in black and white >>>
Alas, you've figured it out. Hence the crickets...
Bernie Madoff never told anyone what he was doing before he got arrested.
What a dolt... What is wrong with you?
She got rich diluting shareholders to the tune of 99.999%. 😂
JMHO as usual
LOL, serious questions only please.. IBRX info.... German Col could likely be one of the lying paid pumpers. IMO
Short % of Float (Apr 15, 2024) 39.03%
Net Income Avi to Common (ttm) -$583.2M
Total Cash (mrq) $266.46M
Correction , $3.2 Billion!!!!
Market Cap (intraday) 3.26B
They will need to raise money soon... IMHO
Another overvalued biotech... $2.3 billion Market Cap with no marketable product.
Almost 80% owned by insiders. Very little institutional interest
<<< and all the years of your shared great due diligence. >>>
Great due Diligence??????? That is a contradiction in terms. lol
He was wrong the whole time, and finally admitted it... to his credit.
Again, change your screen name... It makes no sense.
You are not an investor, IMO.
You are a day dreaming bag holder who knows nothing about companies or stocks
That is not true, most biotechs fail..
You are not a ship captain going down with a ship you designed... , there is no honor in going down with a stock.. In fact, it's just silly.
They people who are called Bashers have been the ones explaining to you why all those crazy pump predictions were wrong and ridiculous. Had you listened to them over the years, you'd be thanking them today! Just sayin'
<<< The overly unrealistic "aproval before February", "last time you see SP under $3", etc... etc... etc...
create far more damage than any basher could do. >>>
<<< Possibly their thinking is a lower price today will translate to a lower buyout price, if that were to happen. >>>
Possibly your thinking would have Sigmund Freud confused and considering a new career path?
Yes, and that someone might be your fearless CEO, who has been printing shares like Kinkos. !!!!!
Just opining here and spitballing a bit
Did you notice my question mark at the end? "?"
Do do know what that symbol represents????? ???? ???? ????
Enough already with the fake excuses....
04/23/24 - 1,204,236,917
04/20/24 - 1,204,039,742
04/17/24 - 1,203,973,067
04/12/24 - 1,203,199,607
04/11/24 - 1,201,099,732
04/10/24 - 1,200,500,107
04/06/24 - 1,199,672,730
04/05/24 - 1,198,812,505
04/03/24 - 1,197,237,455
03/28/24 - 1,195,269,485
03/27/24 - 1,194,274,786
03/26/24 - 1,193,493,852
03/19/24 - 1,193,316,128
03/15/24 - 1,193,166,128
03/14/24 - 1,192,908,369
03/10/24 - 1,192,237,685
03/07/24 - 1,190,170,308
02/29/24 - 1,189,970,308
02/27/24 - 1,188,836,983
02/22/24 - 1,188,731,708
02/17/24 - 1,187,812,280
02/14/24 - 1,186,753,180
02/13/24 - 1,186,425,305
01/30/24 - 1,185,680,827
01/27/24 - 1,185,128,327
01/25/24 - 1,182,971,840
01/24/24 - 1,182,454,590
01/23/24 - 1,182,433,108
01/19/24 - 1,181,833,108
01/09/24 - 1,181,176,418
01/04/24 - 1,175,459,031
01/03/24 - 1,173,563,502
2023:
12/23/23 - 1,172,382,472
01/06/23 - 1,061,044,165
2023 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173492032
2022:
12/21/22 - 1,058,132,006
01/22/22 - 949,180,606
2022 Detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170751056;
2021:
12/31/21 - 947,621,531
01/12/21 - 822,825,147
2020:
12/31/20 - 822,716,397
01/27/20 - 625,187,160
<<< Especially with supposed good news coming. >>>
"Contradictions do not exist. Whenever you think you are facing a contradiction, check your premises. You will find that one of them is wrong."
~ Ayn Rand
Holy Moly $0.46 cents at the close.!
<<< NWBO is advertising the one product they sell. Their stock. >>>
And equally as profitable as their snake oil vaccine
Stop it already with the short crap... Every bid is getting pummeled!
Reg SHO eliminated illegal shorting long ago..
Stop crying and do something smart, like sell?!
JMHO
It means that NWBO is valued at about $600 million right now... I'm saying the patents are worth a few $million dollars at best..
So about 1% of what it's worth now..
JMHO
Pennies on the dollar
.46 handle on the offer now...
<<< Maybe this way if Advent picks the bones for 50 cents, it'll look good?? >>>
Idiotic statement.... Advent wouldn't pay 50 cents for the entire Company, in total!
$0.47 cents is the OFFER now..
Man what a bloodbath.
Approval for a 1:100 reverse split and another 99.999% drop in share price?
You should go and at the very least try and get a free hot dog, baggie...
Dopey, Sneezy, Doc or Sleepy... Whatever your real name is...
Your stock is tanking.
P3 trial was a complete failure ... IMO and the opinions of many scientists..
You have been conned, IMHO
Your stock is going to zero
Little man, do some real research....
No matter what anybody says, NWBO cannot get approval until they run the pediatric trials. This is from the EMA - same rules apply MHRA
"All applications for marketing authorization for new medicines in the EU must include the results of studies as described in an agreed pediatric investigation plan, unless the medicine is exempt because of a deferral or waiver." If a waiver, trials must begin after submission.
NWBO submitted a SAP for pediatric trials, which has been accepted. But until they run - or start to collect enough data to make a case - they are dead in the water. No matter what, they have to run pediatric trials ..... Where is the news that says the company is busy making that happen?
The only information is buried in the Form 10-K
Page 25:
"During 2023 the Company also devoted substantial efforts to preparations for launching the two required pediatric clinical trials."
There is nothing mentioned about enrollment or how she is going to pay for the TWO trials. There is this little note..
Page 10
"Late-stage clinical trials, such as our Phase III clinical trial for GBM patients, are especially expensive, typically requiring tens or hundreds of millions of dollars, and take years to reach their outcomes."
<<<They got permission >>>
From Whom?
<<< very thoroughly vetted, externally proposed, expertized, blinded placebo based >>>
LOL, external controls were bogus! IMO and other scientist's opinion.
Are these the reasons they applied to FDA and EU for approval?? Clown. Your stock is barely holding 46 pennies
From the JAMA filing…
“Given the careful screening to include more favorable patients without signs of progression, we ask the authors to consider presenting complete data for the placebo arm for direct comparison as specified. Despite the urgent need for more effective therapies in glioblastoma, the absence of an ITT analysis suggests that this is a negative trial and that the reported findings are exploratory..”
Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana? Preusser, 2023
"An initial report on the trial in 2018 reported only on the combined overall survival (OS) data of both study arms and failed to report on PFS, the primary study endpoint. The argument for not publishing the primary endpoint was an ambiguous statement about an expert panel being required because of the complex determination of progression.
Now, more than four years later, a second report is available, which is surprisingly named “A Phase 3 Prospective Externally Controlled Cohort Trial”. This is a remarkable title, as the investigators have re-analyzed the OS data of the study against published external controls and present this as a prospective trial. It is obvious, however, that this is not a prospective analysis but a post hoc retrospective analysis: the investigators had seen the data, both of their own study and of the cohorts taken for comparison and then decided to go ahead with cross-trial comparisons."
Possibly .41
I'm wondering if MHRA issued an RFI already and the company is not saying so... Anyone have any idea?
80 working day day clock is about up
Stop talking about AF and focus on your stock that is spiraling down towards zero.....
That's bc there is nothing but sellers out there... They are running for the door while they can
I am not a short, and I certainly WOULD NOT short DAWN... They might be a good takeover target now..
If you want to see what selling on news looks like, stay tuned.
Looks like they are both in a race to zero. 🤣
<<< DcVaxL is for cure >>>
Nothing could be further from the truth. DCVax is a vaccine that was tested as a combo WITH SOC, *Chemo*,... and the trial failed. PFS in the placebo group had longer survival than the DCVax patients. DAWN demonstrated at 51% ORR! Not even in the same universe as DCVax, that's why they have the FDA and US marketing.. NWBO has nothing but clueless shareholders who don't even know what they are invested in!
All that being said, DAWNs market cap is about $1.3 Billion...
Bad news for the bulletin board flim flam . IMO. This is what an FDA stock looks like.
. 89.22% % of Shares Held by Institutions. Mkt Cap $1.3 Billion
. NWBO $600 million, no FDA , .04 % institutions.
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor. $DAWN
https://finance.yahoo.com/news/day-one-ojemda-tovorafenib-receives-195600516.html
Where is Sojourner and his crayon drawings?
The PIP trials haven't even started yet...
Magnificent ignorance!
For $1.92 Million in revenues,...
Makes total sense... 🤣😂🤪
No PIP, no Approval
Show me the trials... I'll wait
Zero stock
EOM
You're on ignore now, pink sheet Patty